Rethinking Clinical Trials

APRIL 27, 2023

The reasoning for this temperature is unclear, though it likely represents what was considered the average body temperature of most patients. In a recent international survey of more than 270 centers, nearly half now use a cooler temperature dialysate in patient care of less than or equal to 36.0

Trials 130

Trials Clinical Trials Clinical Trials Medicine 130

Rethinking Clinical Trials

OCTOBER 27, 2022

Patients use the internet to search for answers, and researchers use the internet to search for new solutions. The Light Collective is an organization that represents collective rights, interests, and voices of patient communities in healthcare technology. Andrea Downing. ePatient and Security Researcher. Key Points. Learn more.

Clinical Research 130

Clinical Research Research Clinical Trials Clinical Trials 130

Pharmaceutical Technology

APRIL 5, 2023

More than a decade after the first patient was treated with a CAR-T therapy, six therapies relying on the same principles have been approved by the US Food and Drug Administration (FDA) and marketed to thousands of patients. How can we better educate the patients? How has the field changed in recent years?

Gene Therapy 147

Gene Therapy Gene Engineer Production 147

XTalks

JANUARY 28, 2022

Up to 50 percent of patients will develop metastatic disease, mainly spreading to the liver, making treatment difficult and limited. Kimmtrak has a price tag of $18,760 per vial, which amounts to a weekly dose. months), so the average cost per patient will be approximately $400,000.

FDA Approval 98

FDA Approval Development Licensing Licensing 98

pharmaphorum

APRIL 27, 2022

AstraZeneca and Daiichi Sankyo have claimed a fifth breakthrough designation from the FDA for Enhertu, shortly after showing the drug extended survival in patients with HER2-low metastatic breast cancer. The post Enhertu gets breakthrough tag in HER2-low breast cancer appeared first on.

Sales 59

Sales Drugs Antibody Licensing 59

World of DTC Marketing

DECEMBER 13, 2021

OPENING: American cancer patients spent more than $21 billion on their care in 2019. billion and patient time costs of $4.87 As cancer survival rates rise, so do the price tags of life-saving treatments. Some cancer patients may face out-of-pocket costs of nearly $12,000 a year for one drug.

Drugs 55

Drugs FDA Approval Medicine Containment 55

Rethinking Clinical Trials

APRIL 13, 2023

Dr. Srinath Adusumalli described a nudge as something that helps make the right choice an easier choice. Useful nudge principles are limitations of information provisions, inertia or status quo bias, choice overload, loss aversion or framing, social ranking and the limits of willpower.

Medicine 100

Medicine Trials Cardiology Development 100

Rethinking Clinical Trials

JANUARY 23, 2024

Feasibility and generalizability affect design choices including inclusion/exclusion criteria, flexibility of imaging intervention being tested, guidance/control of subsequent care after imaging, and endpoints and outcomes. People with angina-like symptoms are often not patients with a disease. They are pretty good.

Trials 152

Trials Cardiology Clinical Trials Clinical Trials 152

Rethinking Clinical Trials

MARCH 21, 2023

Goldberg Distinguished Professor and Chief of Oncology Physician-in-Chief, North Carolina Cancer Hospital Director, Cancer Outcomes Research Program University of North Carolina Slides Keywords Patient-reported outcomes, Oncology, Clinical Trials Key Points Symptoms are common in cancer care. Quality of life (QOL) was assessed at 6 months.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Rethinking Clinical Trials

FEBRUARY 2, 2023

There are many choices clinicians must make for every emergency tracheal intubation for which the effect on patient outcomes is unknown. The data collector was not clinically taking care of the patient but familiar with the procedure and trained on data collection. This results in arbitrary variation in clinical care.

Trials 130

Trials Clinical Trials Clinical Trials Medicine 130

Intouch Solutions

AUGUST 25, 2021

In this POV, we evaluate the potential impact to the email channel and opportunities to continue to deliver ethical, quality email experiences and personalization for pharma customers, including healthcare providers (HCPs) and patients. In terms of scale, there are more than 113 million iPhone users in the United States alone. The result?

Marketing 52

Marketing Regulation Engineer Branding 52

The Pharma Data

MAY 13, 2021

After all, the ingredients we’ve chosen to include in Spade SB-66 are premium ingredients and come with a hefty price tag. Yet while my track record and the success I’ve had with my patients speaks for itself…. And if that’s the choice you make there are no hard feelings from me. This isn’t controversial science….

Packaging 52

Packaging Packaging Containment Production 52

Drug Discovery World

NOVEMBER 13, 2023

Felix Unverdorben, PhD, Associate Director, Immatics Biotechnologies, on: ‘TCER: Next-generation, half-life extended TCR bispecifics designed to maximise efficacy while minimising toxicities for patients’. Jeremy Fry, Dr, Director of Sales, ProImmune, on: ‘Mastering immunogenicity and biologics development’.

Protein 59

Protein Antibody Engineer Scientist 59

Pharma Marketing Network

JUNE 8, 2020

I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication. So yeah, there is plenty to talk about there.

HR 40

HR Marketing Doctors Doctor 40